Intact Investment Management Inc. Has $832,000 Holdings in Cardinal Health, Inc. $CAH

Intact Investment Management Inc. raised its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 1,225.0% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 5,300 shares of the company’s stock after acquiring an additional 4,900 shares during the quarter. Intact Investment Management Inc.’s holdings in Cardinal Health were worth $832,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of the company. Geode Capital Management LLC raised its holdings in shares of Cardinal Health by 3.3% in the second quarter. Geode Capital Management LLC now owns 6,389,049 shares of the company’s stock valued at $1,069,005,000 after buying an additional 205,539 shares during the last quarter. Norges Bank acquired a new position in Cardinal Health in the second quarter valued at about $584,420,000. Invesco Ltd. raised its position in shares of Cardinal Health by 7.3% in the 2nd quarter. Invesco Ltd. now owns 3,037,782 shares of the company’s stock valued at $510,347,000 after acquiring an additional 207,750 shares during the period. Legal & General Group Plc boosted its stake in Cardinal Health by 2.0% during the 2nd quarter. Legal & General Group Plc now owns 2,349,767 shares of the company’s stock worth $394,761,000 after acquiring an additional 45,812 shares during the last quarter. Finally, Marshall Wace LLP grew its holdings in Cardinal Health by 19.1% during the second quarter. Marshall Wace LLP now owns 1,930,967 shares of the company’s stock valued at $324,402,000 after purchasing an additional 309,335 shares during the period. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Price Performance

Cardinal Health stock opened at $210.83 on Tuesday. The company has a market cap of $50.09 billion, a price-to-earnings ratio of 31.80, a P/E/G ratio of 1.41 and a beta of 0.65. The firm has a 50-day moving average of $205.87 and a 200-day moving average of $176.69. Cardinal Health, Inc. has a one year low of $120.72 and a one year high of $215.48.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.22 by $0.33. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The business had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. During the same quarter in the prior year, the company posted $1.88 earnings per share. Cardinal Health’s revenue was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, sell-side analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd were issued a $0.5107 dividend. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend was Friday, January 2nd. Cardinal Health’s dividend payout ratio is presently 30.77%.

Analyst Ratings Changes

A number of brokerages have recently weighed in on CAH. Citigroup raised shares of Cardinal Health from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $190.00 to $244.00 in a research report on Friday, January 9th. Deutsche Bank Aktiengesellschaft raised their price objective on Cardinal Health from $195.00 to $208.00 and gave the stock a “hold” rating in a research note on Tuesday, November 18th. Weiss Ratings reissued a “buy (b)” rating on shares of Cardinal Health in a research note on Wednesday, January 21st. Robert W. Baird set a $250.00 price target on Cardinal Health in a research report on Wednesday, January 14th. Finally, Leerink Partners set a $240.00 price target on shares of Cardinal Health in a research note on Tuesday, January 13th. Fourteen analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Cardinal Health currently has a consensus rating of “Moderate Buy” and an average target price of $221.07.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.